440 related articles for article (PubMed ID: 29964200)
1. The cancer matrisome: From comprehensive characterization to biomarker discovery.
Socovich AM; Naba A
Semin Cell Dev Biol; 2019 May; 89():157-166. PubMed ID: 29964200
[TBL] [Abstract][Full Text] [Related]
2. Exploring the extracellular matrix in health and disease using proteomics.
Taha IN; Naba A
Essays Biochem; 2019 Sep; 63(3):417-432. PubMed ID: 31462529
[TBL] [Abstract][Full Text] [Related]
3. Tumor decellularization reveals proteomic and mechanical characteristics of the extracellular matrix of primary liver cancer.
van Tienderen GS; Conboy J; Muntz I; Willemse J; Tieleman J; Monfils K; Schurink IJ; Demmers JAA; Doukas M; Koenderink GH; van der Laan LJW; Verstegen MMA
Biomater Adv; 2023 Mar; 146():213289. PubMed ID: 36724550
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of the matrisome from MC38 experimental mouse liver metastases.
Yuzhalin AE; Lim SY; Gordon-Weeks AN; Fischer R; Kessler BM; Yu D; Muschel RJ
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G625-G639. PubMed ID: 31545917
[TBL] [Abstract][Full Text] [Related]
5. Ten Years of Extracellular Matrix Proteomics: Accomplishments, Challenges, and Future Perspectives.
Naba A
Mol Cell Proteomics; 2023 Apr; 22(4):100528. PubMed ID: 36918099
[TBL] [Abstract][Full Text] [Related]
6. The in-silico zebrafish matrisome: A new tool to study extracellular matrix gene and protein functions.
Nauroy P; Hughes S; Naba A; Ruggiero F
Matrix Biol; 2018 Jan; 65():5-13. PubMed ID: 28739138
[TBL] [Abstract][Full Text] [Related]
7. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
8. The extracellular matrix: Tools and insights for the "omics" era.
Naba A; Clauser KR; Ding H; Whittaker CA; Carr SA; Hynes RO
Matrix Biol; 2016 Jan; 49():10-24. PubMed ID: 26163349
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix and its therapeutic potential for cancer treatment.
Huang J; Zhang L; Wan D; Zhou L; Zheng S; Lin S; Qiao Y
Signal Transduct Target Ther; 2021 Apr; 6(1):153. PubMed ID: 33888679
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.
Naba A; Clauser KR; Whittaker CA; Carr SA; Tanabe KK; Hynes RO
BMC Cancer; 2014 Jul; 14():518. PubMed ID: 25037231
[TBL] [Abstract][Full Text] [Related]
11. Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in Cancer.
Kääriäinen A; Pesola V; Dittmann A; Kontio J; Koivunen J; Pihlajaniemi T; Izzi V
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33266472
[TBL] [Abstract][Full Text] [Related]
12. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.
Naba A; Clauser KR; Hoersch S; Liu H; Carr SA; Hynes RO
Mol Cell Proteomics; 2012 Apr; 11(4):M111.014647. PubMed ID: 22159717
[TBL] [Abstract][Full Text] [Related]
13. The alternative matrisome: Alternative splicing of ECM proteins in development, homeostasis and tumor progression.
Rekad Z; Izzi V; Lamba R; Ciais D; Van Obberghen-Schilling E
Matrix Biol; 2022 Aug; 111():26-52. PubMed ID: 35537652
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Characterization of the Extracellular Matrix of Human Uterine Fibroids.
Jamaluddin MFB; Nahar P; Tanwar PS
Endocrinology; 2018 Jul; 159(7):2656-2669. PubMed ID: 29788081
[TBL] [Abstract][Full Text] [Related]
15. Charting the unexplored extracellular matrix in cancer.
Filipe EC; Chitty JL; Cox TR
Int J Exp Pathol; 2018 Apr; 99(2):58-76. PubMed ID: 29671911
[TBL] [Abstract][Full Text] [Related]
16. Degradomics technologies in matrisome exploration.
Haack AM; Overall CM; Auf dem Keller U
Matrix Biol; 2022 Dec; 114():1-17. PubMed ID: 36280126
[TBL] [Abstract][Full Text] [Related]
17. Divide-and-Conquer Matrisome Protein (DC-MaP) Strategy: An MS-Friendly Approach to Proteomic Matrisome Characterization.
Ouni E; Ruys SPD; Dolmans MM; Herinckx G; Vertommen D; Amorim CA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266304
[TBL] [Abstract][Full Text] [Related]
18. Targeted matrisome analysis identifies thrombospondin-2 and tenascin-C in aligned collagen stroma from invasive breast carcinoma.
Tomko LA; Hill RC; Barrett A; Szulczewski JM; Conklin MW; Eliceiri KW; Keely PJ; Hansen KC; Ponik SM
Sci Rep; 2018 Aug; 8(1):12941. PubMed ID: 30154546
[TBL] [Abstract][Full Text] [Related]
19. In Depth Quantification of Extracellular Matrix Proteins from Human Pancreas.
Ma F; Tremmel DM; Li Z; Lietz CB; Sackett SD; Odorico JS; Li L
J Proteome Res; 2019 Aug; 18(8):3156-3165. PubMed ID: 31200599
[TBL] [Abstract][Full Text] [Related]
20. A pan-cancer analysis of matrisome proteins reveals CTHRC1 and a related network as major ECM regulators across cancers.
Harikrishnan K; Prabhu SS; Balasubramanian N
PLoS One; 2022; 17(10):e0270063. PubMed ID: 36190948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
